Skip to main content

Table 1 Characteristics of studies

From: Falls among geriatric cancer patients: a systematic review and meta-analysis of prevalence and risk across cancer types

Study

country

Study design

Age (mean)

N

Abraham_2011 [14]

USA

Retrospective

74.5

60,265

Aburub_2020 [15]

Canada

Cross-sectional

69.3

175

Anderson_2022 [16]

USA

Cross-sectional

75(median)

1024

Arora_2022 [17]

USA

Cross-sectional

70

505

Arrieta_2019 [18]

France

Randomized clinical trial

76.7

301

Bartlett_2020 [19]

USA

Retrospective

75.8

425

Basal_2019 [20]

USA

Prospective

63

667

Bjerre_2019 [21]

Denmark

Randomized clinical trial

68.4

214

Blackwood_2021 [22]

USA

Prospective

72.62

34

Bluethmann_2020 [23]

USA

Cross-sectional

74.4

1203

Bylow_2008 [24]

USA

Prospective

78(median)

50

Chen_2014 [25]

USA

Prospective

75.41

1630

Childs_2021 [26]

USA

Retrospective

62

300

Cobbing_2024 [27]

Canada

Prospective

74

198

Eriksen_2022 [28]

Norway

Prospective

73.6

298

Fagard_2017 [29]

Belgium

Prospective

77(median)

115

Fahimnia_2018 [30]

USA

Retrospective

80(median)

806

Farcet_2016 [31]

France

Cross-sectional

83.2

217

Feliu_2021 [32]

Spain

Prospective

77(median)

493

Gewandter_2015 [33]

USA

Retrospective

80(median)

103

Godby_2021 [34]

USA

Cross-sectional

70.0

355

Grothe_2014 [35]

Germany

Retrospective

70

285

Guerard_2015 [36]

USA

Cross-sectional

71(median)

528

Gupta_2023 [37]

USA

Retrospective

62(median)

1571

Habib_2024 [38]

Canada

Cross-sectional

75.4

320

Hamid_2022 [39]

Ireland

Retrospective

76.49

94

Hines_2024 [40]

USA

Retrospective

71.7

4792

Huang_2017 [41]

USA

Cross-sectional

74.2

12,659

Hurria_2009 [42]

USA

Prospective

73

500

Hussain_2010 [9]

Canada

Prospective

69.6

260

Isleyen_2023 [43]

Turkey

Cross-sectional

73.0

180

Jensen-Battaglia_2022 [44]

USA

Randomized clinical trial

75.88

541

Jespersen_2021 [45]

Denmark

Prospective

75.5(median)

170

Ji_2024 [4]

USA

Prospective

70

497

Jolly_2015 [46]

Canada

Cross-sectional

77

90

Jun_2018 [47]

Korea

Retrospective

62.1

356

Kalariya_2024 [48]

USA

Retrospective

78.1

156

Kenis_2022 [49]

Belgium

Prospective

80.0(median)

3681

Kikuchi_2019 [50]

USA

Retrospective

76

429

Kim_2022 [51]

USA

Randomized clinical trial

68

122

Komatsu_2018 [52]

Japan

Cross-sectional

68

98

Kong_2014 [53]

China

Prospective

Not available

52

Korc-Grodzicki_2015 [54]

USA

Retrospective

80(median)

416

Liu_2023 [55]

China

Cross-sectional

71.29

161

LoConte_2013 [56]

USA

Retrospective

 > 64

36,781

Loh_2017 [57]

USA

Cross-sectional

81(median)

389

Lund_2024 [58]

Denmark

Prospective

74

238

Mariano_2015 [59]

Canada

Prospective

77

90

Martí-Dillet_2023 [60]

Spain

Prospective

Not available

117

May_2020 [61]

Ireland

Prospective

77.7

174

Mir_2020 [62]

USA

Cross-sectional

70

264

Mohamed_2024 [63]

USA

Randomized clinical trial

77.2

616

Mohile_2011 [8]

USA

Cross-sectional

76.19

2349

Nassani_2013 [64]

Lebanon

Cross-sectional

76(median)

100

Overcash_2007 [65]

USA

Prospective

77.6

165

Paillaud_2014 [66]

France

Prospective

80.0

519

Pan_2020 [67]

USA

Randomized clinical trial

70

2019

Pandya_2016 [68]

USA

Cross-sectional

78.5

24,271

Patel_2015 [69]

Australia

Retrospective

77(median)

385

Pautex_2008 [70]

Switzerland

Prospective

71.0

198

Peeters_2019 [71]

Belgium

Prospective

 > 70

3681

Pergolotti_2014 [72]

USA

Retrospective

71(median)

524

Piper_2024 [73]

Denmark

Cross-sectional

74.4

200

Pollock_2023 [74]

USA

Randomized clinical trial

74.0(median)

803

Rattanakrong_2022 [75]

Thailand

Prospective

Not available

123

Reyes_2023 [76]

USA

Retrospective

67.7

83

Rosko_2019 [77]

USA

Prospective

Not available

100

Saarelainen_2014 [78]

Australia

Prospective

76.7

383

Sattar_2019 [79]

Canada

Cross-sectional

76(median)

100

Spoelstra_2010 [7]

USA

Cross-sectional

79.5

911

Sulicka_2018 [80]

Poland

Cross-sectional

79.4

286

Tennison_2021 [81]

USA

Prospective

Not available

198

Tomczak_2021 [82]

USA

Prospective

72.2

51

Turner_2016 [83]

Australia

Cross-sectional

76.7

385

Vande Walle_2014 [84]

Belgium

Prospective

76

937

Vetrano_2016 [85]

Europe

Retrospective

82.2

802

Villani_2022 [86]

Italy

Cross-sectional

83.4

442

Whittle_2017 [87]

UK

Prospective

73.9

417

Wildes_2018 [3]

USA

Case–control

76.4

234

Wildes_2018 [88]

USA

Cross-sectional

73

498

Williams_2015 [89]

USA

Prospective

73

1172

Williams_2020 [90]

USA

Prospective

70.1(median)

336

Winters-Stone_2011 [91]

USA

Retrospective

Not available

143

Wu_2016 [92]

Taiwan

Retrospective

74.2

1748

Zak_2017 [93]

Poland

Cross-sectional

70.2

102

Zhang_2018 [94]

USA

Retrospective

78.4

304